David W Dodick on Muck Rack

David W Dodick

Phoenix
As seen in: Color Research & Application, Wiley Online Library, Memory Studies, MDPI, SAGE Publishing, Scientific American, Alzheimer's Research and Therapy, JAMA (The Journal of the American Medical Association), JAMA: Journal of the American Medical Association, Medscape and
Professor (Emeritus), Mayo Clinic. Chair, American Brain Foundation
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with David W

Contact David W, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Headache: The Journal of Head and Face Pain | AHS Journal | Wiley Online Library

|
By Richard Lipton, David W Dodick, Linda Davis
| Wiley Online Library Verified
5-HT 5-hydroxytryptamine AE adverse event CGRP calcitonin gene–related peptide CVD cardiovascular disease MBS most bothersome symptom MOH medication overuse headache NMA network meta-analysis NNT number needed to treat PRN as needed QALY quality-adjusted life year INTRODUCTION Acute treatments for migraine aim to relieve pain and symptoms, restore function, reduce disability, and prevent progression; they should be offered to all patients with a confirmed diagnosis of migraine.1 Effective...
Open in Who Shared Issue with article?

Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache: Final Results From a Phase 4 Randomized Placebo‐Controlled Study

|
By Stewart Tepper, David W Dodick, Michel Lanteri-Minet, David Dolezil
| Wiley Online Library Verified
1 Introduction Medication overuse headache (MOH) is recognized by the International Classification of Headache Disorders, Third Edition (ICHD-3), as a secondary, chronic headache disorder defined by sustained overuse of acute headache medication(s) with significant worsening of a preexisting headache or development of a chronic headache pattern (i.e., ≥ 15 headache days/month for more than 3 months) [1].
Open in Who Shared Issue with article?

World Brain Day 2025

|
By Tissa Wijeratne, Oam Md, David W Dodick
| wfneurology.org
Brain health isn’t a moment in time—it’s a lifelong commitment. World Brain Day 2025 is our call to action to protect neurological well-being from the earliest stages of development, through childhood, adulthood and into older age. It’s a commitment to care, equity, and access for all. Prof.
Open in Who Shared Issue with article?
See all 52 licensed articles (53 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified